Statement Of Cash Flows [Abstract]

GenSight Biologics S.A. - Filing #832858

Concept 2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
As at
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
As at
2021-12-31
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Profit (loss)
EUR
26,220,000 EUR
26,220,000 EUR
EUR
EUR
EUR
EUR
27,625,000 EUR
27,625,000 EUR
EUR
Adjustments to reconcile profit (loss) [abstract]
Adjustments for decrease (increase) in trade accounts receivable
1,000 EUR
756,000 EUR
Adjustments for decrease (increase) in other operating receivables
7,886,000 EUR
5,760,000 EUR
Adjustments for increase (decrease) in trade accounts payable
2,234,000 EUR
2,152,000 EUR
Adjustments for depreciation and amortisation expense
2,179,000 EUR
1,061,000 EUR
Adjustments for share-based payments
587,000 EUR
3,364,000 EUR
Other adjustments for non-cash items
- EUR
- EUR
Cash flows from (used in) operating activities
24,663,000 EUR
33,753,000 EUR
Cash flows from (used in) investing activities [abstract]
Purchase of property, plant and equipment, classified as investing activities
10,000 EUR
252,000 EUR
Purchase of intangible assets, classified as investing activities
0 EUR
0 EUR
Cash flows from (used in) investing activities
209,000 EUR
172,000 EUR
Cash flows from (used in) financing activities [abstract]
Proceeds from issuing shares
3,957,000 EUR
1,000 EUR
Proceeds from borrowings, classified as financing activities
14,182,000 EUR
10,800,000 EUR
Repayments of borrowings, classified as financing activities
1,081,000 EUR
7,822,000 EUR
Payments of lease liabilities, classified as financing activities
792,000 EUR
860,000 EUR
Interest paid, classified as financing activities
368,000 EUR
1,867,000 EUR
Cash flows from (used in) financing activities
15,859,000 EUR
95,000 EUR
Increase (decrease) in cash and cash equivalents before effect of exchange rate changes
8,595,000 EUR
33,487,000 EUR
Effect of exchange rate changes on cash and cash equivalents [abstract]
Effect of exchange rate changes on cash and cash equivalents
119,000 EUR
193,000 EUR
Cash and cash equivalents
2,134,000 EUR
10,610,000 EUR
44,288,000 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.